摘要
目的:观察唑来膦酸1年1次治疗早期股骨头坏死的临床疗效。方法:对2009年1月~2013年1月接受唑来膦酸1年1次注射治疗的23例早期股骨头坏死患者的临床资料及临床疗效进行回顾性分析。结果:本组共23例患者均获随访,随访时间15~22个月,平均16.6个月。根据Harris评分标准,19例患者症状明显改善,4例患者无明显效果,总有效率达82.6%。结论:唑来膦酸能有效治疗早期股骨头坏死,但对其远期效果有待进一步研究。
Objective :To evaluate the clinical results of Zoledronic Acid treatment once yearly of early - stage osteonerosis of the fem- oral head. Methods:Twenty- three patients with early- stage osteonerosis of the femoral head who had received Zoledronic Acid treat- mere once yearly in our hospital between January 2009 to January 2013 , were involved in our retrospective investigation. Results:All pa- tients were followed up prospectively for an average of 16.6 months( range 15 months to 22 months). According to the Harris criteria, 19 cases were excellent, and 4 cases were poor. The total effective rate was 82.6%. Conclusion:Zoledronic Acid is effective in treatment of early - stage osteonerosis of the femoral head. However, its long - term effect is worth researching in future.
出处
《中国伤残医学》
2013年第11期10-11,共2页
Chinese Journal of Trauma and Disability Medicine
基金
盐城市科技计划项目(YK20100054)
关键词
股骨头坏死
早期阶段
唑来膦酸
Osteonerosis of the femoral head
Early - stage
Zoledronic Acid